Literature DB >> 27003771

Prognostic value of p53 protein expression in giant cell tumor of bone.

Ulviye Yalcinkaya1, Nesrin Ugras, Selva Kabul, Gokhan Ocakoglu, Muhammed S Bilgen.   

Abstract

Giant cell tumor of bone (GCTB) is a benign tumor with a tendency for local recurrence. GCTB may cause lung metastases, and secondary malignant GCTB is rare. Its histological appearance does not predict local aggressiveness and/or the metastatic potential of the tumor. We aimed to investigate the prognostic value of the Ki-67 proliferative index and p53 protein expression in GCTB in predicting local recurrence, lung metastasis, and malignant transformation. We retrospectively reviewed 42 cases of GCTB. The p53 expression was positive in 20 cases. We used 10% as a cut-off value for p53 expression. In 10 cases, there were local recurrences. Lung metastases were found in three cases and malignant transformation was found in one case with classical GCTB located in the sacrum three years following diagnosis. The Ki-67 index was higher in cases with recurrence, but this difference was not statistically significant. Of the recurrent cases, two had no p53 staining while eight had moderate-to-strong staining. The staining was usually weakly positive in the non-recurrent cases. In conclusion, we believe that p53 may be used as a marker for the biological behavior of GCTB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27003771     DOI: 10.5114/pjp.2015.57252

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  5 in total

1.  A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Ke Nie; Huishu Yuan; Min-Ying Su; Ning Lang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

2.  Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.

Authors:  Qi-Zheng Wang; En-Long Zhang; Xiao-Ying Xing; Min-Ying Su; Ning Lang
Journal:  Orthop Surg       Date:  2021-11-28       Impact factor: 2.071

3.  Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio patients with giant cell tumor of bone.

Authors:  Aliekber Yapar; İsmail Burak Atalay; Mehmet Ali Tokgöz; Coşkun Ulucaköy; Bedii Şafak Güngör
Journal:  Afr Health Sci       Date:  2021-09       Impact factor: 0.927

4.  Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate?

Authors:  Mate E Maros; Peter Balla; Tamas Micsik; Zoltan Sapi; Miklos Szendroi; Holger Wenz; Christoph Groden; Ramses G Forsyth; Piero Picci; Tibor Krenacs
Journal:  Pathol Oncol Res       Date:  2021-05-03       Impact factor: 3.201

5.  The prognosis of giant cell tumor of bone and the vital risk factors that affect its postoperative recurrence: a meta-analysis.

Authors:  Xunge Lin; Jiaqi Liu; Meng Xu
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.